logo

Hematopoietic Stem Cell Transplantation Market - Growth, Trends, and Forecasts (2020-2025)

The Hematopoietic Stem Cell Transplantation market is segmented by type (Autologous Transplant, Allogenic Transplant), Indication, Application and Geography

Home Industry Reports Healthcare Hematopoietic Stem Cell Transplantation Market - Growth, Trends, and Forecasts ( ...

Market Snapshot

Hematopoietic stem Cell Transplantation market
Study Period: 2017-2025
Base Year: 2019
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The hematopoietic stem cell transplantation market studied is expected to grow with an anticipated CAGR of 6.2%, during the forecast period.

The major drivers propelling the growth of hematopoietic stem cell transplantation market are the increasing prevalence of leukemia and lymphoproliferative disorders globally. The increasing technological advancements along with increased investments in the research and development activities by major players are expected to drive the market. According to the GLOBOCAN 2018 report, the global incidence of leukemia was estimated to 437,033 new cases and nearly 309,006 deaths in 2018. According, to the World Health Organization (WHO), more than 2000 Cord blood Hematopoietic Stem Cell Transplants are performed annually. Thus, considering the mentioned facts and key drivers, the studied market is anticipated to propel over the forecast period.

Scope of the Report

Hematopoietic stem cell transplantation is a procedure that involves the intravenous infusion of autologous or allogeneic stem cells to reestablish hematopoietic function in patients whose bone marrow or immune system is damaged or defective.

By Type
Autologous Transplant
Allogenic Transplant
By Indication
Leukemia
Lymphoproliferative Disorders
Non-Malignant Disorders
By Application
Bone Marrow Transplant
Peripheral Blood Stem Cell Transplant
Cord Blood Transplant
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

By Application, The Bone Marrow Transplant is Expected to Increase over the Forecast Period

A Bone Marrow transplant involves the administration of healthy hematopoietic stem cells in patients with dysfunctional or depleted bone marrow. This procedure is used to treat certain types of cancers, such as leukemia, myeloma, and lymphoma, and other blood and immune system diseases that affect the bone marrow. The Australian Bone Marrow Donor Registry (ABMDR) has over 168,000 volunteer bone marrow donors as of 2019 from over 50 countries and over 35 million people have joined the bone marrow registries worldwide. Also, the increasin R&D activities is expected to boost the segment. For instance, in Oct 2020, Gamida Cell Ltd., announced that the Phase 3 study of omidubicel, an investigational advanced cell therapy in development as a potential life-saving treatment option for patients in need of bone marrow transplant, met all three of its secondary endpoints. Thus, in view of the increasing incidence of target disease and the rising number of donors, the bone marrow transplant is expected to grow significantly over the forecast period.

hematooietic stem cell transplantation trend Market_ Graph.png

North America has a dominant share in Hematopoietic Stem cell Transplantation market and is anticipated to grow tremendously over the forecast period also

The increasing prevalence of leukemia, lymphoproliferative disorders and other target diseases, along with the increasing adoption to the personalized medicine is expected to drive the hematopoietic stem cell transplantation market in North America. According to the Leukemia and Lymphoma Society's facts and Statistics, an estimated combined total of 178,520 people in the United States are expected to be diagnosed with leukemia, lymphoma or myeloma in 2020 and new cases of leukemia, lymphoma and myeloma are expected to account for 9.9 percent of the estimated 1,806,590 new cancer cases diagnosed in the United States in 2020. Additionally, the increasing concentration major players such as ThermoGenesis Holding, Inc., is expected to drive to the growth of the hematopoietc stem cell transplantation market in North America.

hematopoietic stem cell transplantation Market geo_ Graph.png

Competitive Landscape

The Hematopoietic Stem Cell Transplantation market is consolidated and consists of few major players, that dominate the market. However many small and medium sized research laboratories are actively involved in R & D activities related to the studied market, thereby leading to an impactable growth over the forecast period. The major players in Hematopoietic Stem Cell Transplantation market are Merck KGaA, Lonza Group, STEMCELL Technologies, Inc, Pluristem Therapeutics, Inc., ScienCell Research Laboratories, Inc, and many more. The major players are evolving various strategies such as investment in Research and Development, collaborations and acquisitions. For instance, In Jan 2019, Cesca Therapeutics Inc., that is involved in automated cellular processing and autologous cell therapies for regenerative medicineacquired ThermoGenesis Corp. and changed the name from Cesca Therapeutics, Inc. to ThermoGenesis Holdings, Inc. in Nov 2019.

hematopoietic stem cell transplantation Market Conc_ Graph.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Leukemia and Lymphoproliferative Disorders

      2. 4.2.2 Increasing R&D activities by Biotechnology Companies

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost Associated with the Transplantation Procedures

      2. 4.3.2 Technological Barriers in Culture of Hematopoietic Stem Cells and Side Effects After the Transplantation Procedure

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Autologous Transplant

      2. 5.1.2 Allogenic Transplant

    2. 5.2 By Indication

      1. 5.2.1 Leukemia

      2. 5.2.2 Lymphoproliferative Disorders

      3. 5.2.3 Non-Malignant Disorders

    3. 5.3 By Application

      1. 5.3.1 Bone Marrow Transplant

      2. 5.3.2 Peripheral Blood Stem Cell Transplant

      3. 5.3.3 Cord Blood Transplant

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Regen BioPharma, Inc.

      2. 6.1.2 Thermo Fisher Scientific

      3. 6.1.3 STEMCELL Technologies, Inc.

      4. 6.1.4 Pluristem Therapeutics, Inc.

      5. 6.1.5 Merck KGaA

      6. 6.1.6 Lonza Group

      7. 6.1.7 CellGenix GmbH

      8. 6.1.8 ScienCell Research Laboratories, Inc.

      9. 6.1.9 ThermoGenesis Holdings, Inc.

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Hematopoietic Stem Cell Transplantation Market market is studied from 2017 - 2025.

The Hematopoietic Stem Cell Transplantation Market is growing at a CAGR of 6.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2019.

STEMCELL Technologies, Inc., Pluristem Therapeutics, Inc. , Lonza Group, Merck KGaA, ScienCell Research Laboratories, Inc. are the major companies operating in Hematopoietic Stem Cell Transplantation Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!